SKIP TO CONTENT
Johns Hopkins
  • Home
  • About
  • News
  • Contact
  • Login

    • Early Immunotherapy Shows Promising Results in Advanced Basal Cell Carcinoma

    Early Immunotherapy Shows Promising Results in Advanced Basal Cell Carcinoma

    A new study led by researchers at the Johns Hopkins Kimmel Cancer Center found that patients with advanced basal cell carcinoma (BCC) may benefit from receiving immunotherapy earlier in the course of treatment.

    LEARN MORE

    SEE ALL NEWS
    Recent Posts
    How a Division I athlete who never smoked turned his stage 4 ALK+ lung cancer diagnosis into a fight for a cure Solving a 15-Year Mystery: Scientists Discover How Gut Bacteria Toxin Invades Colon Cells to Trigger Cancer Advances in Treating Women’s Bladder Cancer Elena’s Story: Recurrent Brain Cancer After a year of turmoil, cancer researchers see promising signs for mRNA vaccines AI and Mammograms Single Nutrient Fuels Cancer-Fighting Power of T Cells Alcohol and Cancer Risk Colon Cancer Screening: What You Need to Know
    Johns Hopkins

    2026 © The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.
    Terms of Use Privacy Statement

    LinkedIn
    Back to top